Kennedy Administration's Animal Testing Phase-Out Could Impact Xenotransplantation Research, Critics Warn
Health Secretary Robert F. Kennedy Jr. is pursuing a federal phase-out of animal testing, citing poor predictivity for human health outcomes, with the CDC already transferring primates and NIH halting animal-model-exclusive funding. The shift affects eight NIH-funded primate research centers, with at least one closed and another considering conversion to a sanctuary. The timing concerns researchers who argue xenotransplantation—transplanting animal organs into humans—is approaching clinical breakthroughs that depend on animal studies.
The Kennedy administration is implementing a significant policy shift away from federally funded animal testing, based on the premise that animal models poorly predict human health outcomes. The CDC has begun transferring primates to sanctuaries following staff directives, while the NIH, the largest funder of U.S. biological sciences, has stopped issuing funding opportunities exclusively for animal models. This policy change is affecting the eight NIH-funded National Primate Research Centers across the country, with one already shuttered and another exploring conversion to a sanctuary. The article frames this as an opinion piece warning that the timing could be problematic for xenotransplantation research, a field that relies on animal testing and is reportedly approaching clinical breakthroughs. The piece suggests tension between the administration's animal welfare goals and the research community's scientific needs.
What's missing
The article does not provide specific details on the scientific evidence regarding animal model predictivity for human outcomes, nor does it present counterarguments from the animal testing phase-out advocates or cite specific xenotransplantation breakthroughs that depend on primate studies. The current status of xenotransplantation clinical trials and their specific animal testing requirements are not detailed.
What different sources said
- STAT NewsCenter
Opinion: Ending animal testing could set back xenotransplantation just as the field is poised for a breakthrough
Related
MetaPlate: AI System Generates Personalized Meal Recommendations to Prevent Blood Sugar Spikes
Researchers have developed MetaPlate, an AI-powered tool that uses continuous glucose monitoring data and machine learning to generate personalized meal recommendations aimed at preventing postprandial hyperglycemia in healthy adults. The system combines predictive glucose modeling with counterfactual explanations and large language models to produce actionable, realistic dietary guidance tailored to individual physiological responses. Expert evaluation by registered dietitians showed the system produces clinically plausible recommendations that could serve as a real-time dietary decision-support tool.
Machine Learning Model Outperforms Clinical Scores in Predicting Atrial Fibrillation Risk in Cardiac Patients
Researchers developed interpretable machine learning models (Pre-AF 13 and Pre-AF 9) that predict atrial fibrillation risk in cardiovascular disease patients using data from hospital discharge reports. The models achieved better predictive performance (ROC AUC 0.725-0.735 over 24 months) than four established clinical risk scores (ROC AUC 0.53-0.64). The findings suggest that AI-derived risk scores using routine hospital data could improve identification of high-risk patients for atrial fibrillation.
Bipartisan Insulin Price Cap Legislation Gains Congressional Support
Bipartisan legislation to cap insulin costs at $35 per month for people with private insurance gained four new co-sponsors, including Republican and Democratic senators. The bill was originally introduced in March and is building momentum in Congress. The legislation addresses concerns about insulin affordability, a critical issue for millions of Americans with diabetes.